Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Pisters

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Radiation Oncology|October 21, 2000
The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancerK M Pisters
Seminars in Oncology|October 18, 2001
Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancerK M Pisters
Oncology (Williston Park, N.Y.)|February 1, 1992
Management of nausea and vomiting caused by anticancer drugs: state of the artK M Pisters, M G Kris
Chest Surgery Clinics of North America|March 20, 2001
Treatment of stage I lung cancerG L Walsh, K M Pisters, C Stevens
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1994
Delayed emesis following anticancer chemotherapyM G Kris, K M Pisters, L Hinkley
Cancer|December 1, 1993
Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasoneM G Kris, L Baltzer, K M Pisters, et al.
Cancer|February 1, 1994
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatinL Baltzer, M G Kris, L B Tyson, et al.
Investigational New Drugs|September 18, 1998
Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancerC M Haskell, E Mendoza, K M Pisters, et al.
Journal of the National Cancer Institute|May 6, 1992
Dose-ranging trial of zacopride: the emetic antiemetic?K M Pisters, M G Kris, L B Tyson, et al.
Cancer|January 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapyK M Pisters, M G Kris, L B Tyson, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Radiation Oncology|October 21, 2000
The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancerK M Pisters
Seminars in Oncology|October 18, 2001
Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancerK M Pisters
Oncology (Williston Park, N.Y.)|February 1, 1992
Management of nausea and vomiting caused by anticancer drugs: state of the artK M Pisters, M G Kris
Chest Surgery Clinics of North America|March 20, 2001
Treatment of stage I lung cancerG L Walsh, K M Pisters, C Stevens
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1994
Delayed emesis following anticancer chemotherapyM G Kris, K M Pisters, L Hinkley
Cancer|December 1, 1993
Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasoneM G Kris, L Baltzer, K M Pisters, et al.
Cancer|February 1, 1994
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatinL Baltzer, M G Kris, L B Tyson, et al.
Investigational New Drugs|September 18, 1998
Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancerC M Haskell, E Mendoza, K M Pisters, et al.
Journal of the National Cancer Institute|May 6, 1992
Dose-ranging trial of zacopride: the emetic antiemetic?K M Pisters, M G Kris, L B Tyson, et al.
Cancer|January 1, 1993
Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapyK M Pisters, M G Kris, L B Tyson, et al.
Pageof 5